Skip to main content
. 2024 Apr 1;206(1):57–65. doi: 10.1007/s10549-024-07252-7

Fig. 2.

Fig. 2

a Femoral neck BMD in premenopausal patients according to AI therapy discontinuation at 5 years. b Lumbar spine BMD s in premenopausal patients according to AI therapy discontinuation at 5 years. c Femoral neck BMD in postmenopausal patients according to AI therapy discontinuation at 5 years. d Lumbar spine BMD in postmenopausal patients according to AI therapy discontinuation at 5 years. BL baseline. Green line: AI discontinued at 5 years. Black line: Tamoxifen, LHRH-agonist treatment, no adjuvant endocrine therapy or AI continuing beyond 5 years